Question 1

Who are the top researchers at Galderma (Switzerland)?

Accepted Answer

Ranked on the quality score, Valérie Julia, Rajeev Chavda and Christophe Piketty lead among researchers whose main affiliation is Galderma (Switzerland).

Question 2

What are the most cited papers from Galderma (Switzerland)?

Accepted Answer

The most cited paper from Galderma (Switzerland) is "Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis" (Sonja Ständer, Gil Yosipovitch, Franz Josef Legat et al., 2020), with 281 citations. Next come "Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus" (275) and "Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis" (189).

Question 3

Which research topics does Galderma (Switzerland) publish most on?

Accepted Answer

By volume in 2022-now: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Urticaria and Related Conditions and Medicine and Dermatology Studies History.

Question 4

Which keywords describe research at Galderma (Switzerland)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Filaggrin, Skin Microbiome, Quality of Life, Treatment, Diagnosis, Regulatory T Cells and Immune System.

Question 5

Which fields of science does Galderma (Switzerland) work in?

Accepted Answer

In 2022-now, 76% of research at Galderma (Switzerland) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (72%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (6%). It does 2.6× the world's share of Health Sciences.

Question 6

Is Galderma (Switzerland)'s research output growing?

Accepted Answer

Output in 2022-2025 was 46% higher than in 2018-2021.